Sarah Boyce Avidity Biosciences, Inc. (RNA) insider trading activity

RNA Quotes by TradingView

Sarah Boyce is President and CEO of Avidity Biosciences, Inc.. Currently has a direct ownership of 283,394 shares of RNA, which is worth approximately $20.1 Million. The most recent transaction as insider was on Aug 24, 2022, when has been sold 35,045 shares (Common Stock) at a price of $1.24 per share, resulting in proceeds of $43,456. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 283K
7.35% 3M change
18.52% 12M change
Total Value Held $20.1 Million

Sarah Boyce Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 24 2022
BUY
Exercise of conversion of derivative security
$43,456 $1.24 p/Share
35,045 Added 50.0%
35,045 Common Stock
Aug 15 2022
SELL
Open market or private sale
$2,247 $22.47 p/Share
100 Reduced 100.0%
0 Common Stock
Aug 15 2022
BUY
Exercise of conversion of derivative security
$124 $1.24 p/Share
100 Added 50.0%
100 Common Stock

Also insider at

BLI
Berkeley Lights, Inc. Healthcare
Director
LGND
LIGAND PHARMACEUTICALS INC Healthcare
AHPAW
Avista Public Acquisition Corp. II Financial Services
Director
CTNM
Contineum Therapeutics, Inc.
Director
SB

Sarah Boyce

President and CEO
San Diego, CA

Track Institutional and Insider Activities on RNA

Follow Avidity Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RNA shares.

Notify only if

Insider Trading

Get notified when an Avidity Biosciences, Inc. insider buys or sells RNA shares.

Notify only if

News

Receive news related to Avidity Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RNA